New Methods for ALK Status Diagnosis in Non-Small-Cell sorted by
relevance

Admin15.08.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

702
Admin05.08.2021

Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer

4503
Admin15.07.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

6905
Admin12.07.2021

Biopsy and Mutation Detection Strategies in Non-Small Cell

3709
Admin13.07.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

7000
Admin01.10.2021

Diagnostic algorithm for molecular testing of small bio

7401
Admin16.09.2021

(PDF) Biopsy and Mutation Detection Strategies in Non

3801
Admin01.10.2021

Prevalence of driver mutations in non-small-cell lung

2902
Admin21.08.2021

Incidence and survival of non-small cell lung cancer in

8102
Admin06.09.2021

Figure 2 from New options in the management of intractable

7008
Admin20.08.2021

The Tissue Is the Issue: Personalized Medicine for Non

8000
Admin23.08.2021

Baseline patient characteristics (n 5 216) | Download

Admin10.08.2021

Characteristics of a new EML4-ALK -positive cell line, ABC

2306
Admin02.10.2021

Treatment algorithms for non-small cell lung cancer

Admin02.10.2021

Timeline of targeted therapy development. Abbreviations

3400
Admin08.10.2021

CTC levels at baseline, 2nd and 5th cycle of chemotherapy

6408
Admin12.09.2021

Frontiers | Current Treatment Algorithms for Patients with

502
Admin11.09.2021

(A) PFS with different systemic treatments dependent on

1208
Admin31.08.2021

Status of Anaplastic Lymphoma Kinase (ALK) in Malignant

92010
Admin30.07.2021

Updated guidelines for predictive biomarker testing in

9203
Admin16.08.2021

Therapeutic management of ALK+ nonsmall cell lung cancer

7105